首页> 外文期刊>Clinical nuclear medicine >Comparison of Ga-68-PSMA PET/CT and Contrast-Enhanced MRI on Residual Disease Assessment of Juvenile Nasal Angiofibroma
【24h】

Comparison of Ga-68-PSMA PET/CT and Contrast-Enhanced MRI on Residual Disease Assessment of Juvenile Nasal Angiofibroma

机译:GA-68-PSMA PET / CT和对比增强MRI对幼虫血管瘤残留疾病评估的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Prostate-specific membrane antigen (PSMA) is expressed in the endothelial cells of tumor-associated neovasculature of various nonprostatic benign and malignant neoplasms including juvenile nasopharyngeal angiofibroma (JNA). Positive uptake on PET/CT imaging with Ga-68-labeled PSMA is noted in a patient with residual disease after initial surgery without any abnormal uptake in postoperative fibrosis, in contrast to contrast-enhanced MRI, which was confirmed by biopsy. Ga-68-PSMA PET/CT may be a useful tool clinically for identifying early biochemical recurrences and in specifically differentiating recurrences from surgical site reparative tissue.
机译:前列腺特异性膜抗原(psma)在肿瘤相关的新生动物组合的内皮细胞中表达,这些肿瘤的各种非鼻咽肿瘤和恶性肿瘤,包括少年鼻咽血管血管瘤(JNA)。 在术后术后患者患者患者患有GA-68标记的PSMA的PET / CT成像的阳性摄取,术后纤维化的术后患者患者,与对比增强的MRI相反,其被活组织检查确认。 GA-68-PSMA PET / CT可以是临床上的有用工具,用于鉴定早期生物化学复发,并特别区分来自外科部位的检测组织的复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号